Scarica l'app Stockscreener
60.74
1.47%
0.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol Myers (BMY) Receives FDA Orphan Drug Status for Follicul - GuruFocus
Here's What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Finviz
Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY) - Insider Monkey
Bristol Myers Squibb signs to Life Science Cares National Campaign to advance health equity and fight food insecurity - ROI-NJ
Bristol-Myers Squibb Co (BMY) Stock Price, Trades & News - GuruFocus
LSV Asset Management Purchases 138,119 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Grows Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Brokerages - MarketBeat
Illinois Municipal Retirement Fund Increases Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Caisse Des Depots ET Consignations Sells 21,113 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth - Insider Monkey
The 5 Most Interesting Analyst Questions From Bristol-Myers Squibb's Q4 Earnings Call - Finviz
What Does the Market Think About Bristol-Myers Squibb Co? - Sahm
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY) - GuruFocus
BRISTOL MYERS SQUIBB CO SEC 10-K Report - TradingView
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
SC refuses stay on Zydus cancer drug launch, tells BMS to seek relief in HC - Business Standard
Wealthfront Advisers LLC Sells 17,324 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Oral Anticoagulants Market Is Going to Boom |• Bristol-Myers Squibb • Johnson & Johnson - openPR.com
ING Groep NV Boosts Position in Bristol Myers Squibb Company $BMY - MarketBeat
Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally - GlobeNewswire Inc.
Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patents - The Economic Times
Bristol Myers Squibb’s Stock Is On Sale: Value Trap Or Deep-Value Turnaround Play? - AD HOC NEWS
Is Bristol Myers Squibb (BMY) Pricing Reflecting Its Recent Share Price Rebound? - Yahoo Finance
Bristol-Myers Squibb: Solid Near-Term Execution and 2026 EPS Boost from Eliquis, but Limited Long-Term Visibility Supports Hold Rating - TipRanks
Bristol-Myers Squibb stock rating reiterated by Bernstein at Market Perform - Investing.com India
Bristol-Myers Squibb (BMY) Is Up 8.7% After Profit Rebound And Pipeline OutlookHas The Bull Case Changed? - Yahoo Finance
Bristol Myers Squibb AI Trials And 2026 Readouts Reframe Valuation - Yahoo Finance
Bristol-Myers Squibb (BMY) Is Up 8.7% After Swing To Profit And AI-Focused R&D Push - simplywall.st
Assessing Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Pipeline Optimism - Yahoo Finance UK
Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating - Finviz
Bristol Myers Squibb Company $BMY Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Candriam S.C.A. Cuts Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence - Yahoo Finance
Kinsale Capital Group Inc. Has $7.61 Million Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb Stock Is On Sale: Smart Buy Or Value Trap You’ll Regret? - AD HOC NEWS
Bristol-Myers Squibb Stock: Dividend Giant Under Pressure or Deep-Value Setup? - AD HOC NEWS
Jim Cramer Discusses Bristol Myers's (BMY) Cobenfy Drug - Finviz
Jim Cramer Discusses Bristol Myers’s (BMY) Cobenfy Drug - Insider Monkey
Birmingham Capital Management Co. Inc. AL Reduces Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb (BMY) Returns To US$7.1b Trailing Profit Challenging Bearish Narratives - simplywall.st
Bristol-Myers Squibb stock price target raised to $72 by Guggenheim - Investing.com UK
Bristol-Myers Squibb stock price target raised to $60 by Wells Fargo - Investing.com UK
Bristol-Myers Squibb: A Dividend Gem With Hidden Upside In 2026 (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb (NYSE:BMY) Given New $64.00 Price Target at Citigroup - MarketBeat
Bristol-Myers Squibb stock price target raised to $72 by Guggenheim By Investing.com - Investing.com India
Bristol-Myers Squibb Co (NYSE:BMY) Tops Estimates - FXDailyReport.Com
Bristol-Myers Squibb Co (BMY) Stock Price Up 3.76% on Feb 6 - GuruFocus
Wells Fargo Raises Price Target for Bristol-Myers Squibb (BMY) | BMY Stock News - GuruFocus
What Catalysts Are Rewriting The Story For Bristol Myers Squibb (BMY)? - Yahoo Finance
Bristol Myers Squibb Company $BMY Shares Sold by Wells Trecaso Financial Group LLC - MarketBeat
Bristol-Myers Squibb Company (NYSE:BMY) Q4 2025 Earnings Call Transcript - Insider Monkey
Bristol-Myers Squibb Co. (BMY) PT Raised to $72 at Guggenheim - StreetInsider
BMS reports flat revenue growth for full-year 2025 - Pharmaceutical Technology
BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus - Finviz
Bristol Myers Squibb stock gets positive readthrough from Bayer stroke data - Investing.com
Bristol Myers Squibb Q4 Earnings Call Highlights - Yahoo Finance
Bristol-Myers Squibb (BMY) Exceeds Q4 Earnings Expectations - GuruFocus
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):